Additionally, RCAN3 expression exhibited differential expression across molecular subtypes in cancers, including BRCA, COAD, GBM, HNSC, KIRP, LGG, LIHC, OV, PCPG, PRAD, SKCM, STAD, and uterine corpus endometrial carcinoma (UCEC; Figure 3). Here, RCAN3 is linked to uterine corpus endometrial carcinoma.